COMMUNIQUÉS West-GlobeNewswire

Melinta Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update
09/08/2019
~ Revenue of $16.0 million, Including Net Product Sales of $13.8 million, for the Second Quarter 2019 ~ ~ Reduction of Operating Expenses of 32 Percent, or $16.3 million, Year-Over-Year ~ ~ Commenced Enrollment in [...]
Organogenesis Holdings Inc. Reports Second Quarter and First Half 2019 Financial Results
09/08/2019
CANTON, Mass., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions [...]
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
09/08/2019
THE WOODLANDS, Texas, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Jeffrey L. Wade, J.D., Executive Vice President, Corporate and Administrative Affairs and Chief [...]
Voyager Therapeutics Reports Second Quarter 2019 Financial Results and Corporate Highlights
09/08/2019
Gained worldwide rights to VY-HTT01 for Huntington’s disease, expanding wholly-owned pipeline Presented additional Phase 1b results for VY-AADC in patients with Parkinson’s disease at the 2019 American Academy of [...]
Axovant Announces Corporate Updates and Financial Results for First Fiscal Quarter Ended June 30, 2019
09/08/2019
SUNRISE-PD Phase 2 trial of AXO-LENTI-PD for Parkinson's disease continues to enroll patients in second dose cohort with data expected in the fourth quarter of calendar 2019 Data from patients dosed with AXO-AAV-GM1 and [...]
ContraFect Reports Second Quarter 2019 Financial Results and Provides Business Update
09/08/2019
YONKERS, N.Y., Aug. 09, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and [...]
Avadel Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Company Update
09/08/2019
Better-than-expected Hospital Product revenue improves liquidity position Restructuring and other cost reduction actions on track to realize $80 to $90 million in annualized cost savings REST-ON 69% enrolled; 81 [...]
PLx Pharma Inc. Reports Second Quarter 2019 Results
09/08/2019
--Company completes manufacture of registration batches; remains on track for sNDA submission by year-end-- SPARTA, N.J., Aug. 09, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late [...]
Fennec Provides Business Update and Announces Second Quarter 2019 Financial Results
09/08/2019
Anticipate PEDMARK™ New Drug Application (NDA) completion by early 2020 Strong financial position with $17.5 million in cash and no debt RESEARCH TRIANGLE PARK, N.C., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Fennec [...]
ImmunoCellular Therapeutics: Notice of Proposed Settlement of Derivative Action
09/08/2019
LOS ANGELES, Aug. 09, 2019 (GLOBE NEWSWIRE) -- ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (OTC: IMUC), today issued the following announcement. The following is being released pursuant to an Order of the [...]
Periodic update on transaction details related to Philips’ share repurchases
09/08/2019
August 9, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today reported that in the period from August 2, 2019 up to and including August 8, 2019 a total of 570,565 of its own common shares were [...]
Kohlberg clôture l'acquisition de Bemis Healthcare Packaging Europe, fusionne avec Nelipak
09/08/2019
CRANSTON, Rhode Island, 09 août 2019 (GLOBE NEWSWIRE) -- Nelipak® Corporation, Inc. (« Nelipak »), un fournisseur de premier plan d'emballages conçus sur mesure pour les dispositifs médicaux et les industries [...]
Verona Pharma plc: PDMR Dealing
09/08/2019
LONDON, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
ALK announces new epinephrine auto-injector strategy based on innovative new product for the USA
09/08/2019
ALK's ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) new anaphylaxis strategy is to become a major player in the US epinephrine market based on an exclusive deal with Windgap Medical to launch a next generation epinephrine [...]
C-RAD Web Presentation Half-Year Report 2019
09/08/2019
Presentation of the report for the first half of the fiscal year 2019: Date: Friday August 30, 2019 / kl. 11:00 Venue: Online Presentation Topic: C-RAD Half-year report 2019 Procedure: Please register online through the [...]
Change to the Board of Directors and Executive Leadership Team – appointment of Executive Vice President and CFO
09/08/2019
Read the full announcement in PDF Attachment 2019_29_Change to the BoD_and_Executive_Leadership_Team_EN
Novo Nordisk's operating profit increased by 12% in Danish kroner and by 6% at constant exchange rates (CER) in the first six months of 2019
09/08/2019
Sales increased by 9% in Danish kroner and by 5% at CER to DKK 59.3 billion. Sales in International Operations increased by 13% in Danish kroner (12% at CER), driven by growth in all regions. Sales in North America [...]
ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 13-14, 2019
09/08/2019
Geneva, Switzerland and Boston, MA – August 9, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Santhera Announces Executive Management Change
09/08/2019
Pratteln, Switzerland, August 9, 2019 – Santhera Pharmaceuticals (SIX: SANN) announces that Christoph Rentsch has decided to step down as Chief Financial Officer of Santhera by end of this year, in order to pursue his [...]

Pages